 | • レポートコード：D0GIR-12476 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、インフルエンザワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。インフルエンザワクチンの種類別市場規模（三価インフルエンザワクチン、四価インフルエンザワクチン）、用途別市場規模（子供用（6ヶ月〜3歳）、大人・3歳以上の子供）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Mylan、CSL、CCBIO、GSK、AstraZeneca、Hulan Bio ・地域別グローバル市場分析 2015年-2020年 ・インフルエンザワクチンの北米市場（アメリカ、カナダ、メキシコ） ・インフルエンザワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・インフルエンザワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・インフルエンザワクチンの南米市場（ブラジル、アルゼンチン） ・インフルエンザワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：三価インフルエンザワクチン、四価インフルエンザワクチン ・用途別分析：子供用（6ヶ月〜3歳）、大人・3歳以上の子供 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Vaccine for Influenza market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Vaccine for Influenza sales will be xx in 2020 from Vaccine for Influenza million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Vaccine for Influenza market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Vaccine for Influenza industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Vaccine for Influenza and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Vaccine for Influenza market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Vaccine for Influenza market has been segmented into
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
By Application, Vaccine for Influenza has been segmented into:
For Children (6 months to 3 years)
For Adults and Children over 3 years
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Vaccine for Influenza market presented in the report. This section sheds light on the sales growth of different regional and country-level Vaccine for Influenza markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Vaccine for Influenza market.
The report offers in-depth assessment of the growth and other aspects of the Vaccine for Influenza market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Vaccine for Influenza Market Share Analysis
Vaccine for Influenza competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Vaccine for Influenza sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Vaccine for Influenza sales, revenue and market share for each player covered in this report.
The major players covered in Vaccine for Influenza are:
Sanofi
Mylan
CSL
CCBIO
GSK
AstraZeneca
Hulan Bio
Among other players domestic and global, Vaccine for Influenza market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine for Influenza product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Vaccine for Influenza, with price, sales, revenue and global market share of Vaccine for Influenza in 2018 and 2019.
Chapter 3, the Vaccine for Influenza competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine for Influenza breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Vaccine for Influenza market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Vaccine for Influenza sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Vaccine for Influenza Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Vaccine for Influenza Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Vaccine for Influenza Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Overview of Global Vaccine for Influenza Market
1.4.1 Global Vaccine for Influenza Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Vaccine for Influenza Industry Impact
1.6.1 COVID-19 Potential Implications for the Vaccine for Influenza
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Vaccine for Influenza
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Vaccine for Influenza Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Vaccine for Influenza Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 CSL SWOT Analysis
2.3.4 CSL Product and Services
2.3.5 CSL Vaccine for Influenza Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CCBIO
2.4.1 CCBIO Details
2.4.2 CCBIO Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 CCBIO SWOT Analysis
2.4.4 CCBIO Product and Services
2.4.5 CCBIO Vaccine for Influenza Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GSK SWOT Analysis
2.5.4 GSK Product and Services
2.5.5 GSK Vaccine for Influenza Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AstraZeneca Product and Services
2.6.4 AstraZeneca Vaccine for Influenza Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hulan Bio
2.7.1 Hulan Bio Details
2.7.2 Hulan Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Hulan Bio Product and Services
2.7.4 Hulan Bio Vaccine for Influenza Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Vaccine for Influenza Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Vaccine for Influenza Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Vaccine for Influenza Manufacturer Market Share in 2019
3.3.2 Top 6 Vaccine for Influenza Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Vaccine for Influenza Sales, Revenue and Market Share by Regions
4.1.1 Global Vaccine for Influenza Sales and Market Share by Regions (2015-2020)
4.1.2 Global Vaccine for Influenza Revenue and Market Share by Regions (2015-2020)
4.2 North America Vaccine for Influenza Sales and Growth Rate (2015-2020)
4.3 Europe Vaccine for Influenza Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Vaccine for Influenza Sales and Growth Rate (2015-2020)
4.5 South America Vaccine for Influenza Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Vaccine for Influenza Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Vaccine for Influenza Sales, Revenue and Market Share by Country
5.1.1 North America Vaccine for Influenza Sales and Market Share by Country (2015-2020)
5.1.2 North America Vaccine for Influenza Revenue and Market Share by Country (2015-2020)
5.2 United States Vaccine for Influenza Sales and Growth Rate (2015-2020)
5.3 Canada Vaccine for Influenza Sales and Growth Rate (2015-2020)
5.4 Mexico Vaccine for Influenza Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Vaccine for Influenza Sales, Revenue and Market Share by Country
6.1.1 Europe Vaccine for Influenza Sales and Market Share by Country (2015-2020)
6.1.2 Europe Vaccine for Influenza Revenue and Market Share by Country (2015-2020)
6.2 Germany Vaccine for Influenza Sales and Growth Rate (2015-2020)
6.3 UK Vaccine for Influenza Sales and Growth Rate (2015-2020)
6.4 France Vaccine for Influenza Sales and Growth Rate (2015-2020)
6.5 Russia Vaccine for Influenza Sales and Growth Rate (2015-2020)
6.6 Italy Vaccine for Influenza Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Vaccine for Influenza Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Vaccine for Influenza Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Vaccine for Influenza Revenue and Market Share by Regions (2015-2020)
7.2 China Vaccine for Influenza Sales and Growth Rate (2015-2020)
7.3 Japan Vaccine for Influenza Sales and Growth Rate (2015-2020)
7.4 Korea Vaccine for Influenza Sales and Growth Rate (2015-2020)
7.5 India Vaccine for Influenza Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Vaccine for Influenza Sales and Growth Rate (2015-2020)
7.7 Australia Vaccine for Influenza Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Vaccine for Influenza Sales, Revenue and Market Share by Country
8.1.1 South America Vaccine for Influenza Sales and Market Share by Country (2015-2020)
8.1.2 South America Vaccine for Influenza Revenue and Market Share by Country (2015-2020)
8.2 Brazil Vaccine for Influenza Sales and Growth Rate (2015-2020)
8.3 Argentina Vaccine for Influenza Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Vaccine for Influenza Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Vaccine for Influenza Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Vaccine for Influenza Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Vaccine for Influenza Sales and Growth Rate (2015-2020)
9.3 Turkey Vaccine for Influenza Sales and Growth Rate (2015-2020)
9.4 Egypt Vaccine for Influenza Sales and Growth Rate (2015-2020)
9.5 South Africa Vaccine for Influenza Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Vaccine for Influenza Sales and Market Share by Type (2015-2020)
10.2 Global Vaccine for Influenza Revenue and Market Share by Type (2015-2020)
10.3 Global Vaccine for Influenza Price by Type (2015-2020)
11 Global Vaccine for Influenza Market Segment by Application
11.1 Global Vaccine for Influenza Sales Market Share by Application (2015-2020)
11.2 Global Vaccine for Influenza Revenue Market Share by Application (2015-2020)
11.3 Global Vaccine for Influenza Price by Application (2015-2020)
12 Market Forecast
12.1 Global Vaccine for Influenza Sales, Revenue and Growth Rate (2021-2025)
12.2 Vaccine for Influenza Market Forecast by Regions (2021-2025)
12.2.1 North America Vaccine for Influenza Market Forecast (2021-2025)
12.2.2 Europe Vaccine for Influenza Market Forecast (2021-2025)
12.2.3 Asia-Pacific Vaccine for Influenza Market Forecast (2021-2025)
12.2.4 South America Vaccine for Influenza Market Forecast (2021-2025)
12.2.5 Middle East & Africa Vaccine for Influenza Market Forecast (2021-2025)
12.3 Vaccine for Influenza Market Forecast by Type (2021-2025)
12.3.1 Global Vaccine for Influenza Sales Forecast by Type (2021-2025)
12.3.2 Global Vaccine for Influenza Market Share Forecast by Type (2021-2025)
12.4 Vaccine for Influenza Market Forecast by Application (2021-2025)
12.4.1 Global Vaccine for Influenza Sales Forecast by Application (2021-2025)
12.4.2 Global Vaccine for Influenza Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Vaccine for Influenza Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Vaccine for Influenza by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Vaccine for Influenza Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Vaccine for Influenza Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Vaccine for Influenza Major Business
Table 10. Sanofi Vaccine for Influenza Total Revenue (USD Million) (2018-2019)
Table 11. Sanofi SWOT Analysis
Table 12. Sanofi Vaccine for Influenza Product and Services
Table 13. Sanofi Vaccine for Influenza Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Mylan Basic Information, Manufacturing Base and Competitors
Table 15. Mylan Vaccine for Influenza Major Business
Table 16. Mylan Vaccine for Influenza Total Revenue (USD Million) (2018-2019)
Table 17. Mylan SWOT Analysis
Table 18. Mylan Vaccine for Influenza Product and Services
Table 19. Mylan Vaccine for Influenza Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. CSL Basic Information, Manufacturing Base and Competitors
Table 21. CSL Vaccine for Influenza Major Business
Table 22. CSL Vaccine for Influenza Total Revenue (USD Million) (2018-2019)
Table 23. CSL SWOT Analysis
Table 24. CSL Vaccine for Influenza Product and Services
Table 25. CSL Vaccine for Influenza Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. CCBIO Basic Information, Manufacturing Base and Competitors
Table 27. CCBIO Vaccine for Influenza Major Business
Table 28. CCBIO Vaccine for Influenza Total Revenue (USD Million) (2018-2019)
Table 29. CCBIO SWOT Analysis
Table 30. CCBIO Vaccine for Influenza Product and Services
Table 31. CCBIO Vaccine for Influenza Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. GSK Basic Information, Manufacturing Base and Competitors
Table 33. GSK Vaccine for Influenza Major Business
Table 34. GSK Vaccine for Influenza Total Revenue (USD Million) (2018-2019)
Table 35. GSK SWOT Analysis
Table 36. GSK Vaccine for Influenza Product and Services
Table 37. GSK Vaccine for Influenza Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Vaccine for Influenza Major Business
Table 40. AstraZeneca Vaccine for Influenza Total Revenue (USD Million) (2018-2019)
Table 41. AstraZeneca SWOT Analysis
Table 42. AstraZeneca Vaccine for Influenza Product and Services
Table 43. AstraZeneca Vaccine for Influenza Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Hulan Bio Basic Information, Manufacturing Base and Competitors
Table 45. Hulan Bio Vaccine for Influenza Major Business
Table 46. Hulan Bio Vaccine for Influenza Total Revenue (USD Million) (2018-2019)
Table 47. Hulan Bio SWOT Analysis
Table 48. Hulan Bio Vaccine for Influenza Product and Services
Table 49. Hulan Bio Vaccine for Influenza Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Global Vaccine for Influenza Sales by Manufacturer (2018-2019) (K Units)
Table 51. Global Vaccine for Influenza Revenue by Manufacturer (2018-2019) (USD Million)
Table 52. Global Vaccine for Influenza Sales by Regions (2015-2020) (K Units)
Table 53. Global Vaccine for Influenza Sales Market Share by Regions (2015-2020)
Table 54. Global Vaccine for Influenza Revenue by Regions (2015-2020) (USD Million)
Table 55. North America Vaccine for Influenza Sales by Countries (2015-2020) (K Units)
Table 56. North America Vaccine for Influenza Sales Market Share by Countries (2015-2020)
Table 57. North America Vaccine for Influenza Revenue by Countries (2015-2020) (USD Million)
Table 58. North America Vaccine for Influenza Revenue Market Share by Countries (2015-2020)
Table 59. Europe Vaccine for Influenza Sales by Countries (2015-2020) (K Units)
Table 60. Europe Vaccine for Influenza Sales Market Share by Countries (2015-2020)
Table 61. Europe Vaccine for Influenza Revenue by Countries (2015-2020) (USD Million)
Table 62. Asia-Pacific Vaccine for Influenza Sales by Regions (2015-2020) (K Units)
Table 63. Asia-Pacific Vaccine for Influenza Sales Market Share by Regions (2015-2020)
Table 64. Asia-Pacific Vaccine for Influenza Revenue by Regions (2015-2020) (USD Million)
Table 65. South America Vaccine for Influenza Sales by Countries (2015-2020) (K Units)
Table 66. South America Vaccine for Influenza Sales Market Share by Countries (2015-2020)
Table 67. South America Vaccine for Influenza Revenue by Countries (2015-2020) (USD Million)
Table 68. South America Vaccine for Influenza Revenue Market Share by Countries (2015-2020)
Table 69. Middle East & Africa Vaccine for Influenza Sales by Countries (2015-2020) (K Units)
Table 70. Middle East & Africa Vaccine for Influenza Sales Market Share by Countries (2015-2020)
Table 71. Middle East & Africa Vaccine for Influenza Revenue by Countries (2015-2020) (USD Million)
Table 72. Middle East & Africa Vaccine for Influenza Revenue Market Share by Countries (2015-2020)
Table 73. Global Vaccine for Influenza Sales by Type (2015-2020) (K Units)
Table 74. Global Vaccine for Influenza Sales Share by Type (2015-2020)
Table 75. Global Vaccine for Influenza Revenue by Type (2015-2020) (USD Million)
Table 76. Global Vaccine for Influenza Revenue Share by Type (2015-2020)
Table 77. Global Vaccine for Influenza Sales by Application (2015-2020) (K Units)
Table 78. Global Vaccine for Influenza Sales Share by Application (2015-2020)
Table 79. Global Vaccine for Influenza Sales Forecast by Regions (2021-2025) (K Units)
Table 80. Global Vaccine for Influenza Market Share Forecast by Regions (2021-2025)
Table 81. Global Vaccine for Influenza Sales Forecast by Type (2021-2025) (K Units)
Table 82. Global Vaccine for Influenza Market Share Forecast by Type (2021-2025)
Table 83. Global Vaccine for Influenza Sales Forecast by Application (2021-2025)
Table 84. Global Vaccine for Influenza Market Share Forecast by Application (2021-2025)
Table 85. Direct Channel Pros & Cons
Table 86. Indirect Channel Pros & Cons
Table 87. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Vaccine for Influenza Picture
Figure 2. Global Sales Market Share of Vaccine for Influenza by Type in 2019
Figure 3. Trivalent Influenza Vaccine Picture
Figure 4. Quadrivalent Influenza Vaccine Picture
Figure 5. Vaccine for Influenza Sales Market Share by Application in 2018
Figure 6. For Children (6 months to 3 years) Picture
Figure 7. For Adults and Children over 3 years Picture
Figure 8. Global Vaccine for Influenza Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Vaccine for Influenza Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Vaccine for Influenza Sales Market Share by Manufacturer in 2019
Figure 29. Global Vaccine for Influenza Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Vaccine for Influenza Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Vaccine for Influenza Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Vaccine for Influenza Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Vaccine for Influenza Revenue Market Share by Regions (2015-2020)
Figure 36. Global Vaccine for Influenza Revenue Market Share by Regions in 2018
Figure 37. North America Vaccine for Influenza Sales and Growth Rate (2015-2020)
Figure 38. Europe Vaccine for Influenza Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Vaccine for Influenza Sales and Growth Rate (2015-2020)
Figure 40. South America Vaccine for Influenza Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Vaccine for Influenza Sales and Growth Rate (2015-2020)
Figure 42. North America Vaccine for Influenza Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Vaccine for Influenza Sales Market Share by Countries (2015-2020)
Figure 44. North America Vaccine for Influenza Sales Market Share by Countries in 2018
Figure 45. North America Vaccine for Influenza Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Vaccine for Influenza Revenue Market Share by Countries in 2018
Figure 47. United States Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Vaccine for Influenza Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Vaccine for Influenza Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Vaccine for Influenza Revenue Market Share by Countries in 2019
Figure 53. Germany Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Vaccine for Influenza Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Vaccine for Influenza Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Vaccine for Influenza Revenue Market Share by Regions 2019
Figure 61. China Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Vaccine for Influenza Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Vaccine for Influenza Sales Market Share by Countries in 2019
Figure 68. South America Vaccine for Influenza Revenue Market Share by Countries in 2019
Figure 69. Brazil Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Vaccine for Influenza Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Vaccine for Influenza Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Vaccine for Influenza Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Vaccine for Influenza Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Vaccine for Influenza Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Vaccine for Influenza Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Vaccine for Influenza Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Vaccine for Influenza Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Vaccine for Influenza Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Vaccine for Influenza Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Vaccine for Influenza Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Vaccine for Influenza Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
インフルエンザ（インフルエンザ）ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Flu (Influenza) Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- インフルエンザウイルスベクターワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Influenza Virus Vector Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…
- インフルエンザNA阻害剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Influenza NA Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- エボラワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Ebola Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 分子インフルエンザ検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Molecular Influenza Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…